1zum › Citations

Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant.

Larson HN, Weiner H, Hurley TD
J Biol Chem 280 30550-6 (2005)
Cited: 68 times
EuropePMC logo PMID: 15983043

Abstract

Mitochondrial aldehyde dehydrogenase (ALDH2) is the major enzyme that oxidizes ethanol-derived acetaldehyde. A nearly inactive form of the enzyme, ALDH2*2, is found in about 40% of the East Asian population. This variant enzyme is defined by a glutamate to lysine substitution at residue 487 located within the oligomerization domain. ALDH2*2 has an increased Km for its coenzyme, NAD+, and a decreased kcat, which lead to low activity in vivo. Here we report the 2.1 A crystal structure of ALDH2*2. The structure shows a large disordered region located at the dimer interface that includes much of the coenzyme binding cleft and a loop of residues that form the base of the active site. As a consequence of these structural changes, the variant enzyme exhibits rigid body rotations of its catalytic and coenzyme-binding domains relative to the oligomerization domain. These structural perturbations are the direct result of the inability of lysine 487 to form important stabilizing hydrogen bonds with arginines 264 and 475. Thus, the elevated Km for coenzyme exhibited by this variant probably reflects the energetic penalty for reestablishing this site for productive coenzyme binding, whereas the structural alterations near the active site are consistent with the lowered Vmax.

Reviews - 1zum mentioned but not cited (2)

  1. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D. Physiol Rev 94 1-34 (2014)
  2. Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention. Gao J, Hao Y, Piao X, Gu X. Int J Mol Sci 23 2682 (2022)

Articles - 1zum mentioned but not cited (6)

  1. Structural and functional consequences of coenzyme binding to the inactive asian variant of mitochondrial aldehyde dehydrogenase: roles of residues 475 and 487. Larson HN, Zhou J, Chen Z, Stamler JS, Weiner H, Hurley TD. J Biol Chem 282 12940-12950 (2007)
  2. Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase "Asian" variant. Larson HN, Weiner H, Hurley TD. J Biol Chem 280 30550-30556 (2005)
  3. BCL::SAXS: GPU accelerated Debye method for computation of small angle X-ray scattering profiles. Putnam DK, Weiner BE, Woetzel N, Lowe EW, Meiler J. Proteins 83 1500-1512 (2015)
  4. Structural and functional analysis of betaine aldehyde dehydrogenase from Staphylococcus aureus. Halavaty AS, Rich RL, Chen C, Joo JC, Minasov G, Dubrovska I, Winsor JR, Myszka DG, Duban M, Shuvalova L, Yakunin AF, Anderson WF. Acta Crystallogr D Biol Crystallogr 71 1159-1175 (2015)
  5. Inhibition, crystal structures, and in-solution oligomeric structure of aldehyde dehydrogenase 9A1. Wyatt JW, Korasick DA, Qureshi IA, Campbell AC, Gates KS, Tanner JJ. Arch Biochem Biophys 691 108477 (2020)
  6. E487K-Induced Disorder in Functionally Relevant Dynamics of Mitochondrial Aldehyde Dehydrogenase 2. Matsumoto S, Araki M, Isaka Y, Ono F, Hirohashi K, Ohashi S, Muto M, Okuno Y. Biophys J 119 628-637 (2020)


Reviews citing this publication (22)

  1. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V. Pharmacol Rev 64 520-539 (2012)
  2. Mitochondrial aldehyde dehydrogenase and cardiac diseases. Chen CH, Sun L, Mochly-Rosen D. Cardiovasc Res 88 51-57 (2010)
  3. Why does the bone marrow fail in Fanconi anemia? Garaycoechea JI, Patel KJ. Blood 123 26-34 (2014)
  4. Genetics and alcoholism. Edenberg HJ, Foroud T. Nat Rev Gastroenterol Hepatol 10 487-494 (2013)
  5. Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. Chen Z, Stamler JS. Trends Cardiovasc Med 16 259-265 (2006)
  6. Live and let die: insights into pseudoenzyme mechanisms from structure. Murphy JM, Mace PD, Eyers PA. Curr Opin Struct Biol 47 95-104 (2017)
  7. Bio-Zombie: the rise of pseudoenzymes in biology. Murphy JM, Farhan H, Eyers PA. Biochem Soc Trans 45 537-544 (2017)
  8. Nitroglycerin use in myocardial infarction patients. Ferreira JC, Mochly-Rosen D. Circ J 76 15-21 (2012)
  9. Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease. Grünblatt E, Riederer P. J Neural Transm (Vienna) 123 83-90 (2016)
  10. Insights into Aldehyde Dehydrogenase Enzymes: A Structural Perspective. Shortall K, Djeghader A, Magner E, Soulimane T. Front Mol Biosci 8 659550 (2021)
  11. Mitochondrial aldehyde dehydrogenase 2 activation and cardioprotection. Gong D, Zhang H, Hu S. J Mol Cell Cardiol 55 58-63 (2013)
  12. Aldehyde Dehydrogenase, Liver Disease and Cancer. Wang W, Wang C, Xu H, Gao Y. Int J Biol Sci 16 921-934 (2020)
  13. Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases. Zhao Y, Wang C. Biomed Res Int 2015 174050 (2015)
  14. Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases. Chanana AM, Rhee JW, Wu JC. Curr Opin Cardiol 31 266-274 (2016)
  15. Dead enzymes in the aldehyde dehydrogenase gene family: role in drug metabolism and toxicology. Jackson BC, Thompson DC, Charkoftaki G, Vasiliou V. Expert Opin Drug Metab Toxicol 11 1839-1847 (2015)
  16. Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects. El-Mas MM, Abdel-Rahman AA. Adv Exp Med Biol 1193 1-33 (2019)
  17. Focus on: The cardiovascular system: what did we learn from the French (Paradox)? Mochly-Rosen D, Zakhari S. Alcohol Res Health 33 76-86 (2010)
  18. Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency. Montel RA, Munoz-Zuluaga C, Stiles KM, Crystal RG. Cancer Gene Ther 29 889-896 (2022)
  19. A systems omics-based approach to decode substance use disorders and neuroadaptations. Veerappa A, Pendyala G, Guda C. Neurosci Biobehav Rev 130 61-80 (2021)
  20. Emerging functions of pseudoenzymes. Goldberg T, Sreelatha A. Biochem J 480 715-728 (2023)
  21. The Stage-Based Model of Addiction-Using Drosophila to Investigate Alcohol and Psychostimulant Responses. Cummins-Beebee PN, Chvilicek MM, Rothenfluh A. Int J Mol Sci 24 10909 (2023)
  22. The role of aldehyde dehydrogenase 2 in cardiovascular disease. Zhang J, Guo Y, Zhao X, Pang J, Pan C, Wang J, Wei S, Yu X, Zhang C, Chen Y, Yin H, Xu F. Nat Rev Cardiol 20 495-509 (2023)

Articles citing this publication (38)

  1. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. Science 321 1493-1495 (2008)
  2. Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant. Li H, Borinskaya S, Yoshimura K, Kal'ina N, Marusin A, Stepanov VA, Qin Z, Khaliq S, Lee MY, Yang Y, Mohyuddin A, Gurwitz D, Mehdi SQ, Rogaev E, Jin L, Yankovsky NK, Kidd JR, Kidd KK. Ann Hum Genet 73 335-345 (2009)
  3. Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Perez-Miller S, Younus H, Vanam R, Chen CH, Mochly-Rosen D, Hurley TD. Nat Struct Mol Biol 17 159-164 (2010)
  4. Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme. Stagos D, Chen Y, Brocker C, Donald E, Jackson BC, Orlicky DJ, Thompson DC, Vasiliou V. Drug Metab Dispos 38 1679-1687 (2010)
  5. Pharmacokinetic and pharmacodynamic basis for partial protection against alcoholism in Asians, heterozygous for the variant ALDH2*2 gene allele. Peng GS, Chen YC, Tsao TP, Wang MF, Yin SJ. Pharmacogenet Genomics 17 845-855 (2007)
  6. Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system. Ebert AD, Kodo K, Liang P, Wu H, Huber BC, Riegler J, Churko J, Lee J, de Almeida P, Lan F, Diecke S, Burridge PW, Gold JD, Mochly-Rosen D, Wu JC. Sci Transl Med 6 255ra130 (2014)
  7. Redox-switch modulation of human SSADH by dynamic catalytic loop. Kim YG, Lee S, Kwon OS, Park SY, Lee SJ, Park BJ, Kim KJ. EMBO J 28 959-968 (2009)
  8. The crystal structure of a ternary complex of betaine aldehyde dehydrogenase from Pseudomonas aeruginosa Provides new insight into the reaction mechanism and shows a novel binding mode of the 2'-phosphate of NADP+ and a novel cation binding site. González-Segura L, Rudiño-Piñera E, Muñoz-Clares RA, Horjales E. J Mol Biol 385 542-557 (2009)
  9. Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study. Zhu Y, Zhang D, Zhou D, Li Z, Li Z, Fang L, Yang M, Shan Z, Li H, Chen J, Zhou X, Ye W, Yu S, Li H, Cai L, Liu C, Zhang J, Wang L, Lai Y, Ruan L, Sun Z, Zhang S, Wang H, Liu Y, Xu Y, Ling J, Xu C, Zhang Y, Lv D, Yuan Z, Zhang J, Zhang Y, Shi Y, Lai M. J Cell Mol Med 21 1106-1116 (2017)
  10. Characterization of E. coli tetrameric aldehyde dehydrogenases with atypical properties compared to other aldehyde dehydrogenases. Rodríguez-Zavala JS, Allali-Hassani A, Weiner H. Protein Sci 15 1387-1396 (2006)
  11. Characterization of the East Asian variant of aldehyde dehydrogenase-2: bioactivation of nitroglycerin and effects of Alda-1. Beretta M, Gorren AC, Wenzl MV, Weis R, Russwurm M, Koesling D, Schmidt K, Mayer B. J Biol Chem 285 943-952 (2010)
  12. Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation. Moon KH, Lee YM, Song BJ. Free Radic Biol Med 48 391-398 (2010)
  13. Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque. Pan C, Xing JH, Zhang C, Zhang YM, Zhang LT, Wei SJ, Zhang MX, Wang XP, Yuan QH, Xue L, Wang JL, Cui ZQ, Zhang Y, Xu F, Chen YG. Oncotarget 7 35562-35576 (2016)
  14. Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels. Setoh K, Terao C, Muro S, Kawaguchi T, Tabara Y, Takahashi M, Nakayama T, Kosugi S, Sekine A, Yamada R, Mishima M, Matsuda F. Nat Commun 6 7754 (2015)
  15. Conserved catalytic residues of the ALDH1L1 aldehyde dehydrogenase domain control binding and discharging of the coenzyme. Tsybovsky Y, Krupenko SA. J Biol Chem 286 23357-23367 (2011)
  16. Structural determinants of oligomerization of δ(1)-pyrroline-5-carboxylate dehydrogenase: identification of a hexamerization hot spot. Luo M, Singh RK, Tanner JJ. J Mol Biol 425 3106-3120 (2013)
  17. Vascular bioactivation of nitroglycerin by aldehyde dehydrogenase-2: reaction intermediates revealed by crystallography and mass spectrometry. Lang BS, Gorren AC, Oberdorfer G, Wenzl MV, Furdui CM, Poole LB, Mayer B, Gruber K. J Biol Chem 287 38124-38134 (2012)
  18. Human ALDH1B1 polymorphisms may affect the metabolism of acetaldehyde and all-trans retinaldehyde--in vitro studies and computational modeling. Jackson BC, Reigan P, Miller B, Thompson DC, Vasiliou V. Pharm Res 32 1648-1662 (2015)
  19. Aldehyde Dehydrogenase 2 Ameliorates Chronic Alcohol Consumption-Induced Atrial Fibrillation through Detoxification of 4-HNE. Hsu LA, Tsai FC, Yeh YH, Chang CJ, Kuo CT, Chen WJ, Tsai HY, Chang GJ. Int J Mol Sci 21 E6678 (2020)
  20. Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice. Hirohashi K, Ohashi S, Amanuma Y, Nakai Y, Ida T, Baba K, Mitani Y, Mizumoto A, Yamamoto Y, Kikuchi O, Matsubara J, Yamada A, Miyamoto S, Seno H, Matsuda T, Muto M. Carcinogenesis 41 194-202 (2020)
  21. Annotation of 1350 Common Genetic Variants of the 19 ALDH Multigene Family from Global Human Genome Aggregation Database (gnomAD). Chen CH, Kraemer BR, Lee L, Mochly-Rosen D. Biomolecules 11 1423 (2021)
  22. Alcohol Metabolic Inefficiency: Structural Characterization of Polymorphism-Induced ALDH2 Dysfunctionality and Allosteric Site Identification for Design of Potential Wildtype Reactivators. Adeniji EA, Olotu FA, Soliman MES. Protein J 37 216-222 (2018)
  23. Association of alcohol dehydrogenase and aldehyde dehydrogenase Polymorphism with Spontaneous Deep Intracerebral Haemorrhage in the Taiwan population. Huang YH, Chang KH, Lee YS, Chen CM, Chen YC. Sci Rep 10 3641 (2020)
  24. Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites. Nene A, Chen CH, Disatnik MH, Cruz L, Mochly-Rosen D. J Biomed Sci 24 3 (2017)
  25. Human Second Window Pre-Conditioning and Post-Conditioning by Nitrite Is Influenced by a Common Polymorphism in Mitochondrial Aldehyde Dehydrogenase. Ormerod JO, Evans JD, Contractor H, Beretta M, Arif S, Fernandez BO, Feelisch M, Mayer B, Kharbanda RK, Frenneaux MP, Ashrafian H. JACC Basic Transl Sci 2 13-21 (2017)
  26. Molecular cloning and expression of a second zebrafish aldehyde dehydrogenase 2 gene (aldh2b). Song W, Zou Z, Xu F, Gu X, Xu X, Zhao Q. DNA Seq 17 262-269 (2006)
  27. Characterization of polymorphisms of genes ADH2, ADH3, ALDH2 and CYP2E1 and relationship to the alcoholism in a Colombian population. Méndez C, Rey M. Colomb Med (Cali) 46 176-182 (2015)
  28. Engineering an aldehyde dehydrogenase toward its substrates, 3-hydroxypropanal and NAD+, for enhancing the production of 3-hydroxypropionic acid. Park YS, Choi UJ, Nam NH, Choi SJ, Nasir A, Lee SG, Kim KJ, Jung GY, Choi S, Shim JY, Park S, Yoo TH. Sci Rep 7 17155 (2017)
  29. Computational Investigation of Structural Basis for Enhanced Binding of Isoflavone Analogues with Mitochondrial Aldehyde Dehydrogenase. Zhang Y, Qiu Y, Zhang H. ACS Omega 7 8115-8127 (2022)
  30. Genetic Variations of ALDH (rs671) Are Associated With the Persistence of HBV Infection Among the Chinese Han Population. Shang D, Wang P, Tang W, Mo R, Lai R, Lu J, Li Z, Wang X, Cai W, Wang H, Zhao G, Xie Q, Xiang X. Front Med (Lausanne) 9 811639 (2022)
  31. New insights into the half-of-the-sites reactivity of human aldehyde dehydrogenase 1A1. Yoval-Sánchez B, Pardo JP, Rodríguez-Zavala JS. Proteins 81 1330-1339 (2013)
  32. Catalytic contribution of threonine 244 in human ALDH2. González-Segura L, Ho KK, Perez-Miller S, Weiner H, Hurley TD. Chem Biol Interact 202 32-40 (2013)
  33. The Effect of Ethanol Consumption on Composition and Morphology of Femur Cortical Bone in Wild-Type and ALDH2*2-Homozygous Mice. Malkovskiy AV, Van Wassenhove LD, Goltsev Y, Osei-Sarfo K, Chen CH, Efron B, Gudas LJ, Mochly-Rosen D, Rajadas J. Calcif Tissue Int 108 265-276 (2021)
  34. p53 protects against alcoholic fatty liver disease via ALDH2 inhibition. Yao P, Zhang Z, Liu H, Jiang P, Li W, Du W. EMBO J 42 e112304 (2023)
  35. Efficient expression of codon-adapted human acetaldehyde dehydrogenase 2 cDNA with 6xHis tag in Pichia pastoris. Zhao Y, Lei M, Wu Y, Zhang Z, Wang C. Sci China C Life Sci 52 935-941 (2009)
  36. Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3. Castellví A, Pequerul R, Barracco V, Juanhuix J, Parés X, Farrés J. Commun Biol 5 354 (2022)
  37. SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant. Guo H, Yu X, Liu Y, Paik DT, Justesen JM, Chandy M, Jahng JWS, Zhang T, Wu W, Rwere F, Zhao SR, Pokhrel S, Shivnaraine RV, Mukherjee S, Simon DJ, Manhas A, Zhang A, Chen CH, Rivas MA, Gross ER, Mochly-Rosen D, Wu JC. Sci Transl Med 15 eabp9952 (2023)
  38. Virtual Screening of FDA-Approved Drugs for Enhanced Binding with Mitochondrial Aldehyde Dehydrogenase. Zhou B, Zhang Y, Jiang W, Zhang H. Molecules 27 8773 (2022)


Quick links